← All trials
NCT06450886
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 21, 2024
- Primary completion
- Jan 31, 2029
- Completion date
- Apr 30, 2029
- First posted
- Jun 10, 2024
- Last posted
- Oct 24, 2024
- Enrollment
- 270
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Abcuro, Inc.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.